| Structure |
Chemical Name |
CAS |
MF |
 |
Teriflunomide Impurity 2 |
220512-86-7 |
C12H9F3N2O2 |
 |
Dabigatran iMpurity K |
2225986-95-6 |
C34H41N7O5 |
 |
Paroxetine Impurity 10（Paroxetine HCl Hemihydrate EP Impurity E） |
|
|
![Cefixime impurity 13/Cefixime TBE impurity A/Cefixime tert-Butyl Ester/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-(tert-butoxy)-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20210111/GIF/79368-92-6.gif) |
Cefixime impurity 13/Cefixime TBE impurity A/Cefixime tert-Butyl Ester/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-(tert-butoxy)-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
79368-92-6 |
C20H23N5O7S2 |
|
|
Cilastatin EP Impurity A |
|
|
 |
21-Hydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione |
56016-90-1 |
C22H28O3 |
|
|
Azlocillin Oxide Impurity |
|
|
 |
N-Desmethyl O-Methyl Clobazam |
2009208-96-0 |
C16H15ClN2O3 |
 |
Iohexol EP Impurity F |
1215856-35-1 |
C14H19I2N3O6 |
 |
MAESAQUINONE |
19833-20-6 |
C26H42O4 |
![2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]-](/CAS/20200611/GIF/2137823-20-0.gif) |
2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]- |
2137823-20-0 |
C41H47N5O2S2 |
 |
((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate |
2452301-09-4 |
C25H29ClO8 |
 |
10-Methoxy-1,6-dimethylergolin-8β-methanol |
35155-28-3 |
C18H24N2O2 |
![[6R-[6α,7β(Z)]]-7-[2-Furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure](/CAS/GIF/56271-94-4.gif) |
[6R-[6α,7β(Z)]]-7-[2-Furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure |
56271-94-4 |
C15H15N3O7S |
 |
7-Hydroxy-4-benzopyron |
59887-89-7 |
C9H6O3 |
 |
4,7-Dimethoxyquinoline-6-carboxamide |
2839104-94-6 |
C12H12N2O3 |